Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Chinook Therapeutics
Biotech
Novartis, Versant hope to repeat Chinook’s success with Borealis
Borealis, which was jointly launched by Novartis and Versant, is working on next-generation RNA medicines for kidney disease.
James Waldron
Aug 22, 2024 8:00am
Top 10 smartest deals in biopharma
Jun 24, 2024 6:00am
Novartis' $3.2B Chinook bet takes flight as phase 3 hits goal
Oct 30, 2023 8:16am
Novartis inks $3.2B Chinook buyout to lift kidney disease plans
Jun 12, 2023 4:50am
Chinook grounds phase 1 kidney drug trial over adverse event
Apr 11, 2023 10:40am
Sanofi's John Reed jumps ship for J&J—Chutes & Ladders
Feb 17, 2023 9:30am
